Literature DB >> 30554257

A new frontier for amyloid PET imaging: multiple sclerosis.

Silvia Morbelli1,2, Matteo Bauckneht3,4, Selene Capitanio3,4, Matteo Pardini3,5, Luca Roccatagliata3,6, Flavio Nobili3,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30554257     DOI： 10.1007/s00259-018-4232-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  28 in total

Review 1.  Novel MRI and PET markers of neuroinflammation in multiple sclerosis.

Authors:  Marloes Hagens; Bart van Berckel; Frederik Barkhof
Journal:  Curr Opin Neurol       Date:  2016-06       Impact factor: 5.710

Review 2.  Imaging of microglial activation in MS using PET: Research use and potential future clinical application.

Authors:  Laura Airas; Eero Rissanen; Juha Rinne
Journal:  Mult Scler       Date:  2016-10-22       Impact factor: 6.312

3.  Pittsburgh compound-B PET white matter imaging and cognitive function in late multiple sclerosis.

Authors:  Burcu Zeydan; Val J Lowe; Christopher G Schwarz; Scott A Przybelski; Nirubol Tosakulwong; Samantha M Zuk; Matthew L Senjem; Jeffrey L Gunter; Rosebud O Roberts; Michelle M Mielke; Eduardo E Benarroch; Moses Rodriguez; Mary M Machulda; Timothy G Lesnick; David S Knopman; Ronald C Petersen; Clifford R Jack; Kejal Kantarci; Orhun H Kantarci
Journal:  Mult Scler       Date:  2017-05-05       Impact factor: 6.312

Review 4.  Positron emission tomography imaging in evaluation of MS pathology in vivo.

Authors:  Heidi Högel; Eero Rissanen; Anna Vuorimaa; Laura Airas
Journal:  Mult Scler       Date:  2018-08-09       Impact factor: 6.312

Review 5.  Remyelination: the true regeneration of the central nervous system.

Authors:  A H Crawford; C Chambers; R J M Franklin
Journal:  J Comp Pathol       Date:  2013-07-05       Impact factor: 1.311

6.  Remyelination is extensive in a subset of multiple sclerosis patients.

Authors:  Peter Patrikios; Christine Stadelmann; Alexandra Kutzelnigg; Helmut Rauschka; Manfred Schmidbauer; Henning Laursen; Per Soelberg Sorensen; Wolfgang Brück; Claudia Lucchinetti; Hans Lassmann
Journal:  Brain       Date:  2006-08-18       Impact factor: 13.501

7.  Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-¹¹C]-2-(4'-methylaminophenyl)- 6-hydroxybenzothiazole.

Authors:  Bruno Stankoff; Leorah Freeman; Marie-Stéphane Aigrot; Audrey Chardain; Frédéric Dollé; Anna Williams; Damien Galanaud; Lucie Armand; Stéphane Lehericy; Catherine Lubetzki; Bernard Zalc; Michel Bottlaender
Journal:  Ann Neurol       Date:  2011-02-18       Impact factor: 10.422

8.  The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity.

Authors:  R B Banati; J Newcombe; R N Gunn; A Cagnin; F Turkheimer; F Heppner; G Price; F Wegner; G Giovannoni; D H Miller; G D Perkin; T Smith; A K Hewson; G Bydder; G W Kreutzberg; T Jones; M L Cuzner; R Myers
Journal:  Brain       Date:  2000-11       Impact factor: 13.501

Review 9.  Amyloid Proteins and Their Role in Multiple Sclerosis. Considerations in the Use of Amyloid-PET Imaging.

Authors:  Jordi A Matías-Guiu; Celia Oreja-Guevara; María Nieves Cabrera-Martín; Teresa Moreno-Ramos; José Luis Carreras; Jorge Matías-Guiu
Journal:  Front Neurol       Date:  2016-03-31       Impact factor: 4.003

10.  Amyloid PET imaging in multiple sclerosis: an (18)F-florbetaben study.

Authors:  Jordi A Matías-Guiu; María Nieves Cabrera-Martín; Jorge Matías-Guiu; Celia Oreja-Guevara; Cristina Riola-Parada; Teresa Moreno-Ramos; Juan Arrazola; José Luis Carreras
Journal:  BMC Neurol       Date:  2015-11-25       Impact factor: 2.474
View more
  2 in total

Review 1.  Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers.

Authors:  Matteo Bauckneht; Selene Capitanio; Stefano Raffa; Luca Roccatagliata; Matteo Pardini; Caterina Lapucci; Cecilia Marini; Gianmario Sambuceti; Matilde Inglese; Paolo Gallo; Diego Cecchin; Flavio Nobili; Silvia Morbelli
Journal:  EJNMMI Radiopharm Chem       Date:  2019-04-08

2.  18F-florbetapir PET as a marker of myelin integrity across the Alzheimer's disease spectrum.

Authors:  Alexis Moscoso; Jesús Silva-Rodríguez; Jose Manuel Aldrey; Julia Cortés; Juan Manuel Pías-Peleteiro; Álvaro Ruibal; Pablo Aguiar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-09-28       Impact factor: 9.236
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.